| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |